Introduction
We recently demonstrated the beneficial effects of 4âaminopyridine (4âAP), a potassium channel blocker, in enhancing remyelination and recovery of nerve conduction velocity and motor function after sciatic nerve crush injury in mice. Although muscle atrophy occurs very rapidly after nerve injury, the effect of 4âAP on muscle atrophy and intrinsic muscle contractile function is largely unknown.
Methods
Mice were assigned to sciatic nerve crush injury and noâinjury groups and were followed for 3, 7, and 14 days with/without 4âAP or saline treatment. Morphological, functional, and transcriptional properties of skeletal muscle were assessed.
Results
In addition to improving in vivo function, 4âAP significantly reduced muscle atrophy with increased muscle fiber diameter and contractile force. Reduced muscle atrophy was associated with attenuated expression of atrophyârelated genes and increased expression of proliferating stem cells.
Discussion
These findings provide new insights into the potential therapeutic benefits of 4âAP against nerve injuryâinduced muscle atrophy and dysfunction. Muscle Nerve 60: 192â201, 2019